Stocksigma LogoStocksigma Logo

USFDA Issues Form 483 with Two Observations for Dr. Reddy's FTO-11 Facility

The USFDA concluded a Pre-Approval Inspection (PAI) at Dr. Reddy鈥檚 Laboratories' FTO-11 manufacturing facility in Pydibhimavaram, Andhra Pradesh, conducted

USFDA Issues Form 483 with Two Observations for Dr. Reddy's FTO-11 Facility

Dr Reddys Laboratories Ltd 路 Others (Uncategorized) 路 08 Oct 2026, 9:25 pm

USFDA Issues Form 483 with Two Observations for Dr. Reddy's FTO-11 Facility The USFDA concluded a Pre-Approval Inspection (PAI) at Dr. Reddy鈥檚 Laboratories' FTO-11 manufacturing facility in Pydibhimavaram, Andhra Pradesh, conducted between 5th Oct'26 and 7th Oct'26. Following the audit, the regulator issued a Form 483 containing two observations. The company stated it will address the cited observations within the stipulated timeline.

Original exchange filing (PDF)

More announcements from Dr Reddys Laboratories Ltd

All Dr Reddys Laboratories Ltd announcements